Mostrar el registro sencillo del documento

dc.creatorJomah, Shahamah
dc.creatorBasheeruddin Asdaq, Syed Mohammed
dc.creatorAl-Yamani, Mohammed Jaber
dc.date.accessioned2020-08-12T16:46:39Z
dc.date.available2020-08-12T16:46:39Z
dc.date.created2020
dc.identifier.issn1876-0341spa
dc.identifier.otherhttps://doi.org/10.1016/j.jiph.2020.07.013spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/11878
dc.description.abstractThe unprecedented challenge faced by mankind due to emergence of coronavirus 2019 (COVID-19) Q3 pandemic has obligated researchers across the globe to develop effective medicine for prevention and treatment ofthis deadly infection. The aim ofthis review is to compile recently published research articles on anti-COVID 19 management with their benefits and risk to facilitate decision making of the practitioners and policy makers. Unfortunately, clinical outcomes reported for antivirals are not consistent. Initial favorable reports on lopinavir/ritonavir contradicted by recent studies. Ostalmovir has conflicting reports. Short term therapy of remdesivir claimed to be beneficial. Favipiravir demonstrated good recov ery in some of the cases of COVID-19. Umifenovir (Arbidol) was associated with reduction in mortality in few studies. Overall, until now, U.S. Food and Drug administration issued only emergency use authorization to remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.spa
dc.format.extent10 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.publisherJournal of Infection and Public Healthspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectRemdesivirspa
dc.subjectLopinavir/ritonavirspa
dc.subjectLopinavir/ritonavirspa
dc.subjectFavipiravirspa
dc.subjectUmifenovirspa
dc.titleClinical efficacy of antivirals against novel coronavirus (COVID-19): A reviewspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.jiph.2020.07.013spa


Archivos en el documento

Thumbnail

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento